⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Levi & Korsinsky Notifies Regeneron Pharmaceuticals, Inc. (REGN) Investors – Lead Plaintiff Deadline on September 14, 2026
accessnewswire.com
REGN
Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
REGN
Class Action Alert: Levi & Korsinsky Reminds Regeneron (REGN) Investors of September 14, 2026 Deadline
accessnewswire.com
REGN
REGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
REGN
Securities Fraud Class Action Filed Against Regeneron Pharmaceuticals, Inc. (REGN) – Levi & Korsinsky Reminds Investors of September 14, 2026
accessnewswire.com
REGN
Regeneron Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – REGN
businesswire.com
REGN
Regeneron Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – REGN
businesswire.com
REGN
REGN SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026 Ready to Announce with Confidence?
newsfilecorp.com
REGN
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
businesswire.com
REGN
Shareholders of Regeneron Pharmaceuticals, Inc. (REGN): Protect Your Rights Before September 14, 2026 - Contact Levi & Korsinsky
accessnewswire.com
REGN